Personnel

Theresa A. Toigo named acting director of U.S. FDA Office of Women's Health

Published in Women's Health Weekly, October 27th, 2005

U.S. Food and Drug Administration (FDA) commissioner Lester M. Crawford announced the appointment of Theresa A. Toigo as the acting director of FDA's Office of Women's Health. Toigo is also the director of FDA Office of Special Health Issues (OSHI).

The U.S. Food and Drug Administration's Office of Women's Health (OWH) is a champion for women's health both within and outside the agency.

To achieve its goals, OWH ensures that FDA functions, both regulatory and oversight remain gender sensitive and responsive; works to correct any identified gender disparities in drug, device and biologics testing, and regulation policy; monitors progress of priority...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2005-10-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry